ABOUT

The EHS Task Force has been set up due to the considerable success with the launching of the annual European Health Summit. This platform has been designed to drive policy in the domain of health, aside from organising high-level annual events.
The aim is not only to create a larger healthcare network and provide visibility, but also to be able to steer the process of policy making at the European level and strengthen the link between public and private partnership through the involvement of cross-sectorial stakeholders.

CONFIRMED SPEAKERS

Sandra Gallina

Director General DG SANTE

István Ujhelyi

Member of the European Parliament

Sirpa Pietikäinen

Member of the European Parliament

Csaba Kontor

Health Attaché, Permanent Representation of Hungary to the European Union

Antonella Cardone

CEO Cancer Patients Europe

Martine Pergent

President of International Patient Organization for Primary Immunodeficiencies (IPOPI)

Lilia Luchianov

Policy Officer, DG SANTE

Heike Prinz

Head of Commercial Operations EMEA for the Pharmaceuticals Division and ExCo Member at Bayer AG

Elizabeth Kuiper

Associate Director at European Policy Centre

Patrick Stockebrandt

Head of Division at the Centre for European Policy

Elisabetta Zanon

Director of EU Public Affairs and Advocacy of the Alliance for Regenerative Medicine (ARM)

Enrico Lugli

Group Leader and Head of Facility at Humanitas Research Hospital

Laura Campo

Executive Director International Corporate Affairs, Alzheimer’s disease, Eli Lilly and Company

Ruediger Gatermann

Senior Director EU Policy Strategy at CSL Behring

Mehul Mehta

Chief Medical Officer, Dentons Global Advisors

Mariam Zaidi

Euronews, Euractiv, CNBC Presenter

Sarah-Taïssir Bencharif

EU Health Journalist

Arnaud Thysen

Director General, European Business Summits

Felicia Balan

Partnership Manager, European Business Summits

Alvaro De Lecea

Project Assistant, European Business Summits

TASK FORCE MEETINGS

10 MAY 2023 

Closed meeting

A PHARMA STRATEGY FOR RARE AND NON-COMMUNICABLE DISEASES?

The revision of the EU’s Pharma Strategy offers a once in a generation opportunity to highlight to current shortcomings and opportunities in EU health policy when it comes to rare and non-communicable diseases (cardiovascular disease, diabetes etc.). Given the nature of public-private partnerships in the healthcare landscape, listening to the voices of industry is a key factor when it comes to fostering innovation and translating this into improved patient outcomes.

8 JUNE 2023 

Residence Palace, Brussels

European Health Summit Summer Edition

12 SEPTEMBER 2023 

Closed meeting 

ARTIFICIAL INTELLIGENCE AND THE EUROPEAN HEALTH DATA SPACE

AI offers unprecedented opportunities for healthcare, such as reduced costs, increased automation and rapid data processing. On the other hand, questions of data privacy, bias and vulnerabilities may also increase health inequalities. As the EU moves towards the implementation of the EHDS, engaging with stakeholders and ensuring that opportunities can be properly harnessed will be essential for its success.

SEPTEMBER 2023 

Closed meeting

AN INNOVATIVE AND COMPETITIVE HEALTHCARE INDUSTRIAL POLICY FOR EUROPE

As the EU struggles to attract and maintain R&D and investments in the healthcare sector coupled with strategic vulnerabilities in supply chains, the need to develop home-grown and innovative treatments has never been more apparent. Reducing IP and regulatory hurdles in the EU, along with incentivizing investment, infrastructure and skills will be vital to cultivate a competitive healthcare ecosystem.

Have a question? Contact our team!

Felicia Balan

PROJECT MANAGER

felicia@ebsummit.eu

+32 (0) 4 89 75 55 78

IMG_6357

Alvaro De Lecea

Project Assistant

a.delecea@ebsummit.eu

+32 (0) 2 349 3 595

Untitled design-102
Untitled design-103